Atlas Trials

Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

Clinical trial NCT03053635 · COMPLETED

Trial details

NCT number
NCT03053635
Sponsor
Theralase® Technologies Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
Start date
2016-12-21
Primary completion
2018-08-09
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.